- Home
- CGEN vs ECBK Comparison
CGEN vs ECBK Comparison
Compare CGEN & ECBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- ECBK
- Stock Information
- Founded
- CGEN 1993
- ECBK 1919
- Country
- CGEN Israel
- ECBK United States
- Employees
- CGEN N/A
- ECBK N/A
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- ECBK Banks
- Sector
- CGEN Health Care
- ECBK Finance
- Exchange
- CGEN Nasdaq
- ECBK Nasdaq
- Market Cap
- CGEN 167.4M
- ECBK 151.0M
- IPO Year
- CGEN 2000
- ECBK N/A
- Fundamental
- Price
- CGEN $1.53
- ECBK $16.05
- Analyst Decision
- CGEN
- ECBK
- Analyst Count
- CGEN 0
- ECBK 0
- Target Price
- CGEN N/A
- ECBK N/A
- AVG Volume (30 Days)
- CGEN 236.0K
- ECBK 64.1K
- Earning Date
- CGEN 08-06-2025
- ECBK 07-24-2025
- Dividend Yield
- CGEN N/A
- ECBK N/A
- EPS Growth
- CGEN N/A
- ECBK 52.06
- EPS
- CGEN N/A
- ECBK 0.64
- Revenue
- CGEN $27,589,000.00
- ECBK $27,795,000.00
- Revenue This Year
- CGEN N/A
- ECBK N/A
- Revenue Next Year
- CGEN $105.77
- ECBK N/A
- P/E Ratio
- CGEN N/A
- ECBK $24.93
- Revenue Growth
- CGEN N/A
- ECBK 12.29
- 52 Week Low
- CGEN $1.13
- ECBK $12.50
- 52 Week High
- CGEN $2.66
- ECBK $16.99
- Technical
- Relative Strength Index (RSI)
- CGEN 41.35
- ECBK 54.14
- Support Level
- CGEN $1.49
- ECBK $15.96
- Resistance Level
- CGEN $1.64
- ECBK $16.44
- Average True Range (ATR)
- CGEN 0.08
- ECBK 0.34
- MACD
- CGEN -0.02
- ECBK -0.01
- Stochastic Oscillator
- CGEN 25.00
- ECBK 40.60
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About ECBK ECB Bancorp Inc.
ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.